US Stock MarketDetailed Quotes

EXAS Exact Sciences

Watchlist
  • 63.220
  • -0.640-1.00%
Close Apr 17 16:00 ET
  • 66.000
  • +2.780+4.40%
Post 19:09 ET
11.48BMarket Cap-55946P/E (TTM)

Exact Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
19.93%2.5B
16.98%646.89M
20.12%628.34M
19.26%622.09M
23.82%602.45M
17.95%2.08B
16.71%553M
14.61%523.07M
19.97%521.64M
21.01%486.57M
Operating revenue
19.93%2.5B
16.98%646.89M
20.12%628.34M
19.26%622.09M
23.82%602.45M
17.95%2.08B
16.71%553M
14.61%523.07M
19.97%521.64M
21.01%486.57M
Cost of revenue
13.89%654.2M
16.76%171.82M
13.92%168.53M
8.58%157M
16.48%156.9M
25.21%574.4M
23.60%147.16M
27.86%147.94M
26.84%144.6M
22.45%134.7M
Gross profit
22.23%1.85B
17.06%475.07M
22.57%459.81M
23.35%465.09M
26.62%445.55M
15.41%1.51B
14.40%405.84M
10.11%375.14M
17.52%377.04M
20.47%351.87M
Operating expense
-1.32%2.06B
4.14%542.87M
-10.70%452.96M
2.17%541.52M
-1.18%522.65M
-2.63%2.09B
-9.53%521.28M
5.15%507.25M
7.63%530.04M
-10.75%528.9M
Selling and administrative expenses
2.34%1.62B
1.72%411.03M
2.87%390.55M
4.25%414.5M
0.57%404.3M
-4.80%1.58B
-12.85%404.09M
-0.90%379.67M
9.71%397.6M
-11.42%402M
-Selling and marketing expense
-29.57%203.9M
-22.91%57.59M
-33.54%43.86M
-32.01%49.5M
-30.35%53M
-66.41%289.5M
-88.88%74.7M
-0.91%66M
10.81%72.8M
-59.12%76.1M
-General and administrative expense
9.48%1.42B
7.30%353.45M
10.53%346.69M
12.38%365M
7.79%351.3M
61.47%1.29B
258.33%329.39M
-0.89%313.67M
9.47%324.8M
21.74%325.9M
Research and development costs
8.25%425.88M
21.90%114.92M
22.72%111.45M
-1.87%104.1M
-6.68%95.42M
2.02%393.42M
6.54%94.27M
20.51%90.81M
-0.14%106.08M
-11.52%102.25M
Depreciation amortization depletion
-5.43%92.16M
1.73%23.31M
-2.27%22.99M
-13.00%22.93M
-7.00%22.93M
2.58%97.45M
-4.71%22.91M
-1.73%23.53M
10.63%26.36M
6.31%24.65M
-Depreciation and amortization
-5.43%92.16M
1.73%23.31M
-2.27%22.99M
-13.00%22.93M
-7.00%22.93M
2.58%97.45M
-4.71%22.91M
-1.73%23.53M
10.63%26.36M
6.31%24.65M
Other operating expenses
-692.17%-78.43M
---6.4M
-643.85%-72.03M
----
----
--13.24M
--0
--13.24M
----
----
Operating profit
62.89%-214.35M
41.27%-67.8M
105.18%6.85M
50.04%-76.43M
56.45%-77.1M
30.87%-577.53M
47.87%-115.44M
6.78%-132.11M
10.86%-153M
41.09%-177.03M
Net non-operating interest income expense
-51.63%-29.77M
-45.38%-7.87M
-50.35%-7.87M
-73.31%-7.82M
-18.63%-4.76M
-5.53%-19.63M
-16.14%-5.41M
-11.86%-5.24M
3.03%-4.51M
13.02%-4.02M
Non-operating interest expense
75.60%24.42M
64.76%6.54M
72.57%6.54M
73.31%7.82M
30.04%3.39M
7.98%13.91M
23.39%3.97M
17.15%3.79M
39.92%4.51M
-18.73%2.6M
Total other finance cost
-6.58%5.35M
-7.90%1.33M
-7.96%1.33M
----
-2.41%1.38M
0.00%5.73M
0.00%1.44M
0.00%1.44M
----
-0.07%1.41M
Other net income (expense)
219.84%42.42M
379.36%25.33M
114.21%2.07M
141.47%4.28M
822.60%10.75M
-405.96%-35.39M
-823.05%-9.07M
40.21%-14.53M
-400.67%-10.31M
-104.77%-1.49M
Gain on sale of security
268.41%32.71M
549.51%25.33M
124.06%2.07M
229.82%4.83M
132.95%490K
-161.13%-19.43M
-549.36%-5.64M
-109.72%-8.58M
-208.46%-3.72M
-104.77%-1.49M
Special income (charges)
160.76%9.7M
--0
--0
91.62%-552K
--10.26M
20.98%-15.97M
---3.43M
70.58%-5.95M
---6.59M
--0
-Less:Impairment of capital assets
-96.11%621K
--0
--0
-91.62%552K
--69K
-20.98%15.97M
--3.43M
-70.58%5.95M
--6.59M
--0
-Less:Other special charges
---10.32M
--0
----
----
---10.32M
----
----
----
----
----
Income before tax
68.11%-201.75M
61.23%-50.38M
100.69%1.04M
52.38%-79.92M
60.38%-72.49M
24.92%-632.57M
42.22%-129.93M
11.08%-151.88M
2.93%-167.81M
33.22%-182.95M
Income tax
126.51%2.4M
72.04%-610K
107.99%249K
163.22%1.11M
182.23%1.66M
96.33%-9.06M
48.57%-2.18M
19.23%-3.12M
-143.50%-1.75M
99.17%-2.02M
Net income
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
6.13%-166.06M
-480.60%-180.94M
Net income continuous Operations
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
6.13%-166.06M
-480.60%-180.94M
Minority interest income
Net income attributable to the parent company
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
6.13%-166.06M
-480.60%-180.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
6.13%-166.06M
-480.60%-180.94M
Basic earnings per share
68.08%-1.13
62.50%-0.27
100.52%0.0044
52.13%-0.45
59.62%-0.42
-1.72%-3.54
43.75%-0.72
13.40%-0.84
8.74%-0.94
-477.78%-1.04
Diluted earnings per share
68.08%-1.13
62.50%-0.27
100.51%0.0043
52.13%-0.45
59.62%-0.42
-1.72%-3.54
43.75%-0.72
13.40%-0.84
8.74%-0.94
-477.78%-1.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 19.93%2.5B16.98%646.89M20.12%628.34M19.26%622.09M23.82%602.45M17.95%2.08B16.71%553M14.61%523.07M19.97%521.64M21.01%486.57M
Operating revenue 19.93%2.5B16.98%646.89M20.12%628.34M19.26%622.09M23.82%602.45M17.95%2.08B16.71%553M14.61%523.07M19.97%521.64M21.01%486.57M
Cost of revenue 13.89%654.2M16.76%171.82M13.92%168.53M8.58%157M16.48%156.9M25.21%574.4M23.60%147.16M27.86%147.94M26.84%144.6M22.45%134.7M
Gross profit 22.23%1.85B17.06%475.07M22.57%459.81M23.35%465.09M26.62%445.55M15.41%1.51B14.40%405.84M10.11%375.14M17.52%377.04M20.47%351.87M
Operating expense -1.32%2.06B4.14%542.87M-10.70%452.96M2.17%541.52M-1.18%522.65M-2.63%2.09B-9.53%521.28M5.15%507.25M7.63%530.04M-10.75%528.9M
Selling and administrative expenses 2.34%1.62B1.72%411.03M2.87%390.55M4.25%414.5M0.57%404.3M-4.80%1.58B-12.85%404.09M-0.90%379.67M9.71%397.6M-11.42%402M
-Selling and marketing expense -29.57%203.9M-22.91%57.59M-33.54%43.86M-32.01%49.5M-30.35%53M-66.41%289.5M-88.88%74.7M-0.91%66M10.81%72.8M-59.12%76.1M
-General and administrative expense 9.48%1.42B7.30%353.45M10.53%346.69M12.38%365M7.79%351.3M61.47%1.29B258.33%329.39M-0.89%313.67M9.47%324.8M21.74%325.9M
Research and development costs 8.25%425.88M21.90%114.92M22.72%111.45M-1.87%104.1M-6.68%95.42M2.02%393.42M6.54%94.27M20.51%90.81M-0.14%106.08M-11.52%102.25M
Depreciation amortization depletion -5.43%92.16M1.73%23.31M-2.27%22.99M-13.00%22.93M-7.00%22.93M2.58%97.45M-4.71%22.91M-1.73%23.53M10.63%26.36M6.31%24.65M
-Depreciation and amortization -5.43%92.16M1.73%23.31M-2.27%22.99M-13.00%22.93M-7.00%22.93M2.58%97.45M-4.71%22.91M-1.73%23.53M10.63%26.36M6.31%24.65M
Other operating expenses -692.17%-78.43M---6.4M-643.85%-72.03M----------13.24M--0--13.24M--------
Operating profit 62.89%-214.35M41.27%-67.8M105.18%6.85M50.04%-76.43M56.45%-77.1M30.87%-577.53M47.87%-115.44M6.78%-132.11M10.86%-153M41.09%-177.03M
Net non-operating interest income expense -51.63%-29.77M-45.38%-7.87M-50.35%-7.87M-73.31%-7.82M-18.63%-4.76M-5.53%-19.63M-16.14%-5.41M-11.86%-5.24M3.03%-4.51M13.02%-4.02M
Non-operating interest expense 75.60%24.42M64.76%6.54M72.57%6.54M73.31%7.82M30.04%3.39M7.98%13.91M23.39%3.97M17.15%3.79M39.92%4.51M-18.73%2.6M
Total other finance cost -6.58%5.35M-7.90%1.33M-7.96%1.33M-----2.41%1.38M0.00%5.73M0.00%1.44M0.00%1.44M-----0.07%1.41M
Other net income (expense) 219.84%42.42M379.36%25.33M114.21%2.07M141.47%4.28M822.60%10.75M-405.96%-35.39M-823.05%-9.07M40.21%-14.53M-400.67%-10.31M-104.77%-1.49M
Gain on sale of security 268.41%32.71M549.51%25.33M124.06%2.07M229.82%4.83M132.95%490K-161.13%-19.43M-549.36%-5.64M-109.72%-8.58M-208.46%-3.72M-104.77%-1.49M
Special income (charges) 160.76%9.7M--0--091.62%-552K--10.26M20.98%-15.97M---3.43M70.58%-5.95M---6.59M--0
-Less:Impairment of capital assets -96.11%621K--0--0-91.62%552K--69K-20.98%15.97M--3.43M-70.58%5.95M--6.59M--0
-Less:Other special charges ---10.32M--0-----------10.32M--------------------
Income before tax 68.11%-201.75M61.23%-50.38M100.69%1.04M52.38%-79.92M60.38%-72.49M24.92%-632.57M42.22%-129.93M11.08%-151.88M2.93%-167.81M33.22%-182.95M
Income tax 126.51%2.4M72.04%-610K107.99%249K163.22%1.11M182.23%1.66M96.33%-9.06M48.57%-2.18M19.23%-3.12M-143.50%-1.75M99.17%-2.02M
Net income 67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M6.13%-166.06M-480.60%-180.94M
Net income continuous Operations 67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M6.13%-166.06M-480.60%-180.94M
Minority interest income
Net income attributable to the parent company 67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M6.13%-166.06M-480.60%-180.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M6.13%-166.06M-480.60%-180.94M
Basic earnings per share 68.08%-1.1362.50%-0.27100.52%0.004452.13%-0.4559.62%-0.42-1.72%-3.5443.75%-0.7213.40%-0.848.74%-0.94-477.78%-1.04
Diluted earnings per share 68.08%-1.1362.50%-0.27100.51%0.004352.13%-0.4559.62%-0.42-1.72%-3.5443.75%-0.7213.40%-0.848.74%-0.94-477.78%-1.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Cancer Research
Cancer Research
Intraday-0.31%
ARK Holdings
ARK Holdings
Intraday-0.95%